ImmunoTargets and Therapy

6.4(top 5%)

impact factor

135(top 100%)

papers

3.8K(top 20%)

citations

30(top 20%)

h-index

6.6(top 5%)

extended IF

174

all documents

4.3K

doc citations

57(top 20%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Melanoma treatment in review	ImmunoTargets and Therapy	2018	483
2	The role of adipokines in chronic inflammation	ImmunoTargets and Therapy	2016	274
3	The hygiene hypothesis: current perspectives and future therapies	ImmunoTargets and Therapy	2015	143
4	<p>Immunoinformatics and Vaccine Development: An Overview</p>	ImmunoTargets and Therapy	2020	129
5	Clinical features, predictive correlates, and pathophysiology of immune-related adverse events in immune checkpoint inhibitor treatments in cancer: a short review	ImmunoTargets and Therapy	2017	121
6	<p>Cytokine Release Syndrome: Current Perspectives</p>	ImmunoTargets and Therapy	2019	116
7	<p>Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update</p>	ImmunoTargets and Therapy	2020	116
8	Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse events	ImmunoTargets and Therapy	2017	101
9	CD28 co-stimulation in T-cell homeostasis: a recent perspective	ImmunoTargets and Therapy	2015	97
10	The role of regulatory T cells in cancer immunology	ImmunoTargets and Therapy	2015	96
11	Emerging roles for HMGB1 protein in immunity, inflammation, and cancer	ImmunoTargets and Therapy	2015	94
12	Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments	ImmunoTargets and Therapy	2016	89
13	<p>Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis</p>	ImmunoTargets and Therapy	2020	72
14	<p>Therapeutic Vaccines for HPV-Associated Malignancies</p>	ImmunoTargets and Therapy	2020	66
15	Current perspectives on the immunopathogenesis of systemic sclerosis	ImmunoTargets and Therapy	2016	65
16	The Role of Complement in Synaptic Pruning and Neurodegeneration	ImmunoTargets and Therapy	2021	64
17	<p>GM-CSF: A Promising Target in Inflammation and Autoimmunity</p>	ImmunoTargets and Therapy	2020	59
18	Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma	ImmunoTargets and Therapy	2021	59
19	<p>Targeting IL-4 for the Treatment of Atopic Dermatitis</p>	ImmunoTargets and Therapy	2020	56
20	Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies	ImmunoTargets and Therapy	2016	54
21	Multiple effects of CD40–CD40L axis in immunity against infection and cancer	ImmunoTargets and Therapy	2018	50
22	Review of checkpoint immunotherapy for the management of non-small cell lung cancer	ImmunoTargets and Therapy	2018	48
23	Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment	ImmunoTargets and Therapy	2015	47
24	Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer	ImmunoTargets and Therapy	2017	44
25	Cancer testis antigen and immunotherapy	ImmunoTargets and Therapy	2013	43
26	Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches	ImmunoTargets and Therapy	2021	40
27	Novel perspectives on non-canonical inflammasome activation	ImmunoTargets and Therapy	2015	39
28	Cancer as an immune-mediated disease	ImmunoTargets and Therapy	2012	35
29	Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer	ImmunoTargets and Therapy	2018	34
30	<p>Immunotherapy for Medulloblastoma: Current Perspectives</p>	ImmunoTargets and Therapy	2020	33
31	IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity	ImmunoTargets and Therapy	2020	33
32	Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer's disease	ImmunoTargets and Therapy	2013	32
33	Current and emerging treatment options in the management of lupus	ImmunoTargets and Therapy	2016	32
34	VISTA: A Promising Target for Cancer Immunotherapy?	ImmunoTargets and Therapy	2021	31
35	<p>Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis</p>	ImmunoTargets and Therapy	2020	30
36	The role of autophagy in microbial infection and immunity	ImmunoTargets and Therapy	2015	29
37	<p>Varicella zoster virus vaccines: an update</p>	ImmunoTargets and Therapy	2019	29
38	<p>Cannabidiol as a Novel Therapeutic for Immune Modulation</p>	ImmunoTargets and Therapy	2020	29
39	<p>Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?</p>	ImmunoTargets and Therapy	2020	29
40	Targeting CD22 for the Treatment of B-Cell Malignancies	ImmunoTargets and Therapy	2021	29
41	Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities	ImmunoTargets and Therapy	2013	28
42	Immunotherapy for tuberculosis: future prospects	ImmunoTargets and Therapy	2016	28
43	Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes	ImmunoTargets and Therapy	2017	28
44	Alopecia Areata: An Autoimmune Disease of Multiple Players	ImmunoTargets and Therapy	2021	28
45	Prion diseases: immunotargets and therapy	ImmunoTargets and Therapy	2016	27
46	<p>Complement Inhibition for the Treatment of Myasthenia Gravis</p>	ImmunoTargets and Therapy	2020	27
47	First-line treatment of metastatic melanoma: role of nivolumab	ImmunoTargets and Therapy	2017	26
48	<p>Gasdermin D Hypermethylation Inhibits Pyroptosis And LPS-Induced IL-1β Release From NK92 Cells</p>	ImmunoTargets and Therapy	2019	26
49	Pathophysiology of Non-IgE-Mediated Food Allergy	ImmunoTargets and Therapy	2021	26
50	Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer	ImmunoTargets and Therapy	2012	25

Scientometrics

Overviews

Citing Bodies

ImmunoTargets and Therapy

Top Articles